Here, we investigate the effectiveness of different combinations of three modalities which interfere with DNA integrity or DNA repair: cisplatin (cDDP), mild hyperthermia (heating the tumour to 40–43°C for 1 h) and Poly-(ADP-ribose)-polymerase1 inhibitors (PARP1-i). The gene discussed is PARP1; the disease is neoplasm.